Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
6.33
+0.08 (1.28%)
At close: Apr 3, 2025, 4:00 PM
6.37
+0.04 (0.63%)
After-hours: Apr 3, 2025, 7:03 PM EST
Cryo-Cell International Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cryo-Cell International stock has a target of 8.50, which predicts an increase of 34.28% from the current stock price of 6.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Cryo-Cell International is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $8.5 | Strong Buy | Maintains | $9 → $8.5 | +34.28% | Mar 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +89.57% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
32.69M
from 31.99M
Increased by 2.21%
Revenue Next Year
33.02M
from 32.69M
Increased by 0.98%
EPS This Year
-0.12
from 0.05
EPS Next Year
-0.05
from -0.12
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 33.7M | 34.0M |
| Avg | 32.7M | 33.0M |
| Low | 31.4M | 31.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 5.2% | 4.0% |
| Avg | 2.2% | 1.0% |
| Low | -1.8% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.13 | -0.05 |
| Avg | -0.12 | -0.05 |
| Low | -0.12 | -0.05 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.